Home/ Supplements/ Calcium/ Chewable Calcium Carbonate 260 mg

Chewable Calcium Carbonate 260 mg

product on market Tablet or Pill Freeda Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Chewable Calcium Carbonate 260 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

4 Tablet(s)
Serving Size
25
Servings
Mineral
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
1040 mg (80% DV)

Other Ingredients

Monk Fruit Cellulose Vegetarian Stearate Silica
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Suggested Use: Adults, chew four (4) tablets daily, preferably with food and liquid.

Warnings & Precautions

Keep out of the reach of children

Formulation Notes

No gluten No lactose No artificial colors No artificial flavors No animal derivatives No sugar or starch No gelatin No yeast

Vegan

(Elemental Calcium 260 mg)

NSKC (New Square Rabbinical Kashrus Council) OU Pareve (Kosher)

Additional Information

Manufactured in a GMP certified facility in the USA

Freeda since 1928

NSKC (New Square Rabbinical Kashrus Council) OU Pareve (Kosher)

Store product at room temperature. Do not expose to excessive heat or moisture.

Metadata

Product Details

UPC / SKU7 58487 02721 7
DSLD Entry Date2020-05-22
Product TypeMineral
FormTablet or Pill
BrandFreeda
DSLD ID221401
Data Updated2026-04-11
Research

Research Evidence

511
Research Sources
57
Avg Quality
266
Meta Analysis
95
Systematic Review
76
Rct
49
Clinical Trial
12
Guideline
4
Regulatory Source
2
Cochrane Review
2
Other
2
Narrative Review
1
Openfda Safety
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A First-line drugs for hypertension
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Beta-blockers for hypertension
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Calcium →
Compare

Similar Products

View all Calcium products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.